韩国育龄女性定植B群链球菌耐药谱多样性增加
该研究分析了韩国育龄女性1994-2000年与2017-2022年定植的B群链球菌(GBS)分离株的耐药与分子特征。结果显示克隆复合体由CC19转为CC1,左氧氟沙星耐药率由0%升至23.4%,耐药谱数量由6种增至16种。
要点
- GBS定植株对β-内酰胺类和万古霉素保持敏感。
- 左氧氟沙星耐药率从0%升至23.4%,耐药株多携gyrA和parC。
- 耐药谱数量从6种增至16种,提示耐药多样性增加。
核心结论
- 获得多种耐药基因使定植GBS的耐药谱扩大,需持续全国监测。
研究设计与样本
- 收集三个机构育龄女性宫颈和/或肛直肠拭子GBS分离株246株,1994-2000年37株,2017-2022年209株。
- 采用MicroScan MicroSTREP Plus Panel进行药敏试验,用NovaSeq 6000全基因组测序鉴定ST、CC、cps基因型及耐药基因。
主要发现
- 1994-2000年CC19占优势(35.1%,13/37),2017-2022年CC1最常见(35.4%,74/209)。
- cps基因型VIII从仅限1株ST1变为出现在32株ST2中(P=0.037)。
- 四环素耐药率从97.3%降至60.8%(P<0.001),tetM从91.7%降至72.4%(P<0.001),tetO从2.8%升至29.9%(P=0.017)。
- 左氧氟沙星耐药率从0%升至23.4%(P=0.001),98.0%耐药株同时携带gyrA和parC。
- 耐药谱数量从6种增至16种,含11种新模式,覆盖81.8%左氧氟沙星耐药株。
关键数值与推荐
- 所有分离株对β-内酰胺类和万古霉素敏感。
- 左氧氟沙星耐药株中98.0%携带gyrA和parC。
- 耐药谱从6种增至16种,新增11种模式覆盖81.8%左氧氟沙星耐药株。
临床怎么用
- 对育龄女性GBS定植株应关注左氧氟沙星耐药,治疗前参考药敏结果。
- 持续监测GBS耐药谱变化,尤其CC1克隆及新型耐药模式的出现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An increase of group B Streptococcus (GBS) colonization in pregnant women with a parallel rise in neonatal and infant infections, were observed in Korea. We characterized antimicrobial resistance (AMR) and molecular features of GBS isolates from reproductive-aged women between 1994-2000 and 2017-2022. METHODS: We collected 246 GBS isolates, 37 during 1994-2000 and 209 during 2017-2022, from cervical and/or anorectal swabs at three institutions. Antimicrobial susceptibility was tested using the MicroScan MicroSTREP Plus Panel (Beckman Coulter, Brea, CA, USA). Sequence types (STs), clonal complexes (CCs), cps genotypes by serotypes, and AMR genes were identified using whole-genome sequencing on the NovaSeq 6000 system (Illumina, San Diego, CA, USA). RESULTS: During 1994-2000, CC19 was predominant (35.1%, 13/37), whereas during 2017-2022, CC1 became the most common (35.4%, 74/209). cps genotype VIII, previously limited to one ST1 isolate, appeared in 32 ST2 isolates (P =0.037). All isolates remained susceptible to β-lactams and vancomycin. Tetracycline resistance decreased from 97.3% to 60.8% (P <0.001), with tetM prevalence decreasing from 91.7% to 72.4% (P <0.001) and tetO prevalence increasing from 2.8% to 29.9% (P =0.017). Levofloxacin resistance increased from 0% to 23.4% (P =0.001), with 98.0% of resistant isolates carrying both gyrA and parC. The number of resistance profiles increased from six to 16, including 11 newly identified patterns, covering 81.8% of levofloxacin resistant isolates. CONCLUSIONS: The acquisition of diverse resistance genes has expanded AMR profiles in colonized GBS, emphasizing the need for sustained nationwide surveillance.
引用
- Ahn K, Choi SJ, Bae HG, et al. Increasing Antimicrobial Resistance Profile Diversity of Colonizing Group B Streptococcus in Reproductive-Aged Women in Korea. Ann Lab Med. 2025. PMID: 41189392. doi:10.3343/alm.2025.0439
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。